Patients with multiple sclerosis who are being treated with natalizumab (Tysabri) must be enrolled in a special program called:

Question

Quizplus · Accepted Answer

The special program that patients with multiple sclerosis being treated with natalizumab (Tysabri) must be enrolled in is called TOUCH (Tysabri Outreach: Unified Commitment to Health). This program is intended to monitor patients for a potentially fatal condition called progressive multifocal leukoencephalopathy (PML) which is associated with the use of natalizumab.

Patients with Multiple Sclerosis Who Are Being Treated with Natalizumab